• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿液细胞谱作为狼疮肾炎的生物标志物。

Urinary Cellular Profile as a Biomarker for Lupus Nephritis.

机构信息

From the Department of Internal Medicine, Rheumatology and Clinical Immunology Unit.

Department of Clinical and Chemical Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

出版信息

J Clin Rheumatol. 2021 Dec 1;27(8):e469-e476. doi: 10.1097/RHU.0000000000001553.

DOI:10.1097/RHU.0000000000001553
PMID:32976199
Abstract

BACKGROUND/OBJECTIVE: A search for the ideal biomarker for lupus nephritis (LN) is still underway, one that can be used for early detection and correlate with the class and activity of LN. Urine is normally devoid of leukocytes; however, it has been observed that macrophages and T lymphocytes are routinely present in the urine of LN patients and those with other proliferative renal diseases. This provides the idea for their potential use as biomarkers for proliferative LN. Here, we measured the urinary CD4+, CD8+ T lymphocytes, and CD14+ monocytes in patients with systemic lupus erythematosus (SLE) as potential biomarkers for LN.

METHODS

A longitudinal case-control study included 30 SLE patients with LN, 30 SLE patients without past or current LN, and 20 healthy subjects as a control group. The flow cytometric analysis was done using BD FACS Calibur multiparameter flow cytometer equipped with BD CellQuest Pro software for data analysis.

RESULTS

CD14+ cells were the most abundant cells in the urine of LN patients. The mean numbers of urinary CD8+, CD4+, and CD14+ cells/mL were significantly higher in patients with LN than in those without. The cell counts correlated significantly with proteinuria. Urinary CD14+ cells seem to occur in much higher counts in class IV than class III LN.

CONCLUSIONS

Urinary CD8+, CD4+, and CD14+ cells are highly sensitive and specific markers for detecting proliferative LN. A low CD4:CD8 ratio provides a further clue. Urinary CD14 cell counts may be a potential biomarker to differentiate between the different classes of proliferative LN.

摘要

背景/目的:目前仍在寻找狼疮肾炎(LN)的理想生物标志物,该标志物可用于早期检测,并与 LN 的类型和活动相关。尿液通常不含白细胞;然而,已经观察到 LN 患者和其他增殖性肾脏疾病患者的尿液中经常存在巨噬细胞和 T 淋巴细胞。这为它们作为增殖性 LN 的潜在生物标志物提供了思路。在这里,我们测量了系统性红斑狼疮(SLE)患者尿液中的 CD4+、CD8+T 淋巴细胞和 CD14+单核细胞,作为 LN 的潜在生物标志物。

方法

一项纵向病例对照研究纳入了 30 例 LN 患者、30 例无既往或当前 LN 的 SLE 患者和 20 名健康受试者作为对照组。使用配备有 BD CellQuest Pro 软件的 BD FACS Calibur 多参数流式细胞仪进行流式细胞术分析。

结果

LN 患者尿液中 CD14+细胞最为丰富。LN 患者尿液中 CD8+、CD4+和 CD14+细胞的平均数量明显高于无 LN 患者。细胞计数与蛋白尿显著相关。尿液 CD14+细胞在 IV 级 LN 中似乎出现更高的计数。

结论

尿液 CD8+、CD4+和 CD14+细胞是检测增殖性 LN 的高度敏感和特异标志物。CD4:CD8 比值降低提供了进一步的线索。尿 CD14 细胞计数可能是区分不同类型增殖性 LN 的潜在生物标志物。

相似文献

1
Urinary Cellular Profile as a Biomarker for Lupus Nephritis.尿液细胞谱作为狼疮肾炎的生物标志物。
J Clin Rheumatol. 2021 Dec 1;27(8):e469-e476. doi: 10.1097/RHU.0000000000001553.
2
The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers.狼疮性肾炎中尿液免疫细胞的细胞特征:对潜在生物标志物的新见解
Arthritis Res Ther. 2015 Apr 3;17(1):94. doi: 10.1186/s13075-015-0600-y.
3
Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.采用液质联用技术对尿液白细胞进行深度表型分析,揭示了白细胞特征可早期、无创预测狼疮肾炎治疗应答。
Front Immunol. 2020 Mar 24;11:256. doi: 10.3389/fimmu.2020.00256. eCollection 2020.
4
Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis.尿活化白细胞细胞黏附分子在系统性红斑狼疮和狼疮性肾炎中的临床血清学关联。
Clin Rheumatol. 2024 Mar;43(3):1015-1021. doi: 10.1007/s10067-024-06883-x. Epub 2024 Jan 31.
5
Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4 and CD8 T cells and macrophages.绘制人类狼疮性肾炎中的尿趋化因子图谱:潜在冗余途径招募CD4和CD8 T细胞以及巨噬细胞。
Eur J Immunol. 2017 Jan;47(1):180-192. doi: 10.1002/eji.201646387. Epub 2016 Nov 21.
6
Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.尿转铁蛋白和铜蓝蛋白在系统性红斑狼疮患者中用于鉴别狼疮性肾炎患者的效用。
Reumatol Clin (Engl Ed). 2020 Jan-Feb;16(1):17-23. doi: 10.1016/j.reuma.2018.02.002. Epub 2018 Mar 9.
7
Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response.尿 CD4 T 细胞可识别增生性狼疮肾炎的 SLE 患者,可用于监测治疗反应。
Ann Rheum Dis. 2014 Jan;73(1):277-83. doi: 10.1136/annrheumdis-2012-202784. Epub 2013 Mar 8.
8
Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.尿半乳糖凝集素-3 结合蛋白反映系统性红斑狼疮肾炎活动度。
Lupus. 2023 Feb;32(2):252-262. doi: 10.1177/09612033221145534. Epub 2022 Dec 12.
9
Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare.尿维生素D结合蛋白是狼疮性肾炎的一种新型生物标志物,可预测蛋白尿复发的发生。
Lupus. 2018 Sep;27(10):1600-1615. doi: 10.1177/0961203318778774. Epub 2018 Jun 29.
10
Levels of Proteinuria and Renal Pathology in Systemic Lupus Erythematosus Patients.系统性红斑狼疮患者蛋白尿水平与肾脏病理。
Saudi J Kidney Dis Transpl. 2023 Mar 1;34(2):154-160. doi: 10.4103/1319-2442.391894. Epub 2023 Dec 25.

引用本文的文献

1
Applying 12 machine learning algorithms and Non-negative Matrix Factorization for robust prediction of lupus nephritis.应用 12 种机器学习算法和非负矩阵分解进行狼疮肾炎的稳健预测。
Front Immunol. 2024 Aug 19;15:1391218. doi: 10.3389/fimmu.2024.1391218. eCollection 2024.
2
Investigating the value of urinary biomarkers in relation to lupus nephritis histopathology: present insights and future prospects.探讨尿生物标志物与狼疮性肾炎组织病理学的相关性:当前见解与未来展望。
Front Pharmacol. 2024 Jul 22;15:1421657. doi: 10.3389/fphar.2024.1421657. eCollection 2024.
3
Analysis of m6A-regulated genes and subtype classification in lupus nephritis.
m6A 调控基因分析及狼疮肾炎的亚型分类。
BMC Nephrol. 2024 Apr 3;25(1):119. doi: 10.1186/s12882-024-03549-3.
4
Noninvasive biomarkers for lupus nephritis.狼疮肾炎的无创性生物标志物。
Lab Med. 2024 Sep 4;55(5):535-542. doi: 10.1093/labmed/lmae015.
5
The role of N6-methyladenosine (mA) in kidney diseases.N6-甲基腺苷(m6A)在肾脏疾病中的作用。
Front Med (Lausanne). 2023 Sep 28;10:1247690. doi: 10.3389/fmed.2023.1247690. eCollection 2023.
6
Transcriptome Studies in Lupus Nephritis.狼疮性肾炎的转录组研究
Arch Immunol Ther Exp (Warsz). 2022 Apr 25;70(1):15. doi: 10.1007/s00005-022-00651-y.
7
Exploration of Potential Integrated Models of N6-Methyladenosine Immunity in Systemic Lupus Erythematosus by Bioinformatic Analyses.通过生物信息学分析探索系统性红斑狼疮中 N6-甲基腺苷免疫的潜在综合模型。
Front Immunol. 2022 Feb 7;12:752736. doi: 10.3389/fimmu.2021.752736. eCollection 2021.
8
Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis.免疫相关尿液生物标志物在狼疮肾炎诊断中的应用。
Int J Mol Sci. 2021 Jul 1;22(13):7143. doi: 10.3390/ijms22137143.